We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+6.83%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.1B
AUM Growth
+$2.29B
Cap. Flow
+$1.7B
Cap. Flow %
9.4%
Top 10 Hldgs %
14.26%
Holding
1,826
New
616
Increased
338
Reduced
371
Closed
491
Avg Time Held Equity + Options
2.1 quarters
Top 10 Avg Time Held Equity + Options
1.7 quarters
Top 20 Avg Time Held Equity + Options
1.2 quarters
Avg Time Held Equity only
2.1 quarters
Top 10 Avg Time Held Equity only
1.7 quarters
Top 20 Avg Time Held Equity only
1.2 quarters

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$219M
2
TWX
Time Warner Inc
TWX
+$207M
3
DGX icon
Quest Diagnostics
DGX
+$161M
4
CVS icon
CVS Health
CVS
+$154M
5
PCG icon
PG&E
PCG
+$143M

Top Sells

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$162M
2
TXN icon
Texas Instruments
TXN
+$103M
3
AMZN icon
Amazon
AMZN
+$85.6M
4
DAL icon
Delta Air Lines
DAL
+$76M
5
NVDA icon
NVIDIA
NVDA
+$75.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.55%
2 Technology 14.64%
3 Consumer Discretionary 12.81%
4 Industrials 10.92%
5 Communication Services 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
META icon
1
Meta Platforms (Facebook)
META
$1.89T
$440M 2.43%
2,495,476
+678,447
+37% +$120M
2013 Q3
17 quarters
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.31T
$324M 1.79%
6,145,540
+1,810,800
+42% +$93.5M
2017 Q1
3 quarters
JNJ icon
3
Johnson & Johnson
JNJ
$636B
$289M 1.6%
2,067,353
-360,306
-15% -$50.2M
2017 Q2
2 quarters
ZTS icon
4
Zoetis
ZTS
$31.3B
$258M 1.42%
3,577,907
-105,989
-3% -$7.28M
2013 Q2
18 quarters
BSX icon
5
Boston Scientific
BSX
$63.5B
$256M 1.41%
10,310,777
+7,929,843
+333% +$219M
2017 Q1
3 quarters
PFE icon
6
Pfizer
PFE
$162B
$235M 1.3%
6,845,815
+1,656,002
+32% +$56.5M
2013 Q2
18 quarters
SPGI icon
7
S&P Global
SPGI
$122B
$215M 1.19%
1,267,468
+212,393
+20% +$34.7M
2017 Q1
3 quarters
TWX
8
DELISTED
Time Warner Inc
TWX
$200M 1.11%
+2,188,772
New +$207M
2017 Q4
0 quarters
DGX icon
9
Quest Diagnostics
DGX
$25.7B
$183M 1.01%
1,857,599
+1,700,001
+1,079% +$161M
2017 Q1
3 quarters
DHR icon
10
Danaher
DHR
$156B
$182M 1%
2,209,225
-1,125
-0.1% -$91.5K
2013 Q4
16 quarters
MSFT icon
11
Microsoft
MSFT
$4.02T
$158M 0.88%
1,850,930
+988,797
+115% +$81.1M
2017 Q1
3 quarters
CVS icon
12
CVS Health
CVS
$112B
$153M 0.85%
+2,114,629
New +$154M
2017 Q4
0 quarters
UNH icon
13
UnitedHealth
UNH
$340B
$150M 0.83%
680,815
+400,988
+143% +$85M
2017 Q1
3 quarters
TMUS icon
14
T-Mobile US
TMUS
$163B
$140M 0.77%
2,197,442
+1,741,950
+382% +$106M
2013 Q3
17 quarters
SEE icon
15
DELISTED
Sealed Air
SEE
$138M 0.76%
2,798,716
-433,785
-13% -$19.9M
2017 Q1
3 quarters
MRVL icon
16
Marvell Technology
MRVL
$239B
$138M 0.76%
6,417,455
+4,825,681
+303% +$98.4M
2017 Q1
3 quarters
BABA icon
17
Alibaba
BABA
$276B
$133M 0.73%
771,097
+463,042
+150% +$83M
2017 Q2
2 quarters
LVS icon
18
Las Vegas Sands
LVS
$23.4B
$133M 0.73%
1,908,339
+727,705
+62% +$48.5M
2017 Q3
1 quarter
CSL icon
19
Carlisle Companies
CSL
$12.7B
$132M 0.73%
1,160,888
-103,556
-8% -$11.3M
2017 Q1
3 quarters
PM icon
20
Philip Morris
PM
$315B
$131M 0.72%
1,237,327
+28,553
+2% +$3.04M
2013 Q4
16 quarters
PTC icon
21
PTC
PTC
$21.1B
$129M 0.71%
2,123,984
-98,309
-4% -$6.1M
2017 Q1
3 quarters
A icon
22
Agilent Technologies
A
$48.3B
$125M 0.69%
1,860,498
+819,527
+79% +$55.3M
2013 Q2
18 quarters
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$129B
$123M 0.68%
822,888
+256,709
+45% +$38M
2017 Q1
3 quarters
NVS icon
24
Novartis
NVS
$273B
$120M 0.66%
1,591,500
+623,156
+64% +$47M
2017 Q1
3 quarters
ABT icon
25
Abbott
ABT
$176B
$118M 0.65%
2,071,951
+945,904
+84% +$52.4M
2013 Q3
17 quarters
1
2 3 4 5

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2017 Portfolio in Review

As of Q4 2017, Marshall Wace North America held 1,826 positions worth $18.1B, up 14% from $15.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace North America deployed $1.7B of net new capital in Q4 2017, opening 616 new positions and adding to 338 existing holdings. Its largest new stake was Time Warner Inc: 2,188,772 shares worth $200M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Applied Materials, an estimated $162M trimmed.

  • Marshall Wace North America's largest Q4 2017 buy was Time Warner Inc: 2,188,772 shares worth $200M.
  • Marshall Wace North America added most to Boston Scientific in Q4 2017, an estimated $219M increase.
  • Marshall Wace North America's biggest Q4 2017 reduction was Applied Materials, cutting an estimated $162M.
  • Marshall Wace North America fully exited NVIDIA in Q4 2017, selling an estimated $75.7M.
  • Marshall Wace North America's ten largest holdings make up 14% of its $18.1B portfolio in Q4 2017.
  • Marshall Wace North America opened 616 new positions and closed 491 in Q4 2017.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $18.1B.

Based on Marshall Wace North America's 13F filing for Q4 2017, filed 14 Feb 2018.